These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 8623058)

  • 1. Chemotherapy of adenocarcinoma of the pancreas.
    Schnall SF; Macdonald JS
    Semin Oncol; 1996 Apr; 23(2):220-8. PubMed ID: 8623058
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gemcitabine: progress in the treatment of pancreatic cancer.
    Heinemann V
    Oncology; 2001; 60(1):8-18. PubMed ID: 11150902
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Docetaxel and gemcitabine released for cancer chemotherapy.
    Am J Health Syst Pharm; 1996 Jul; 53(14):1643, 1649. PubMed ID: 8827226
    [No Abstract]   [Full Text] [Related]  

  • 4. A rapid and systematic review of the clinical effectiveness and cost-effectiveness of paclitaxel, docetaxel, gemcitabine and vinorelbine in non-small-cell lung cancer.
    Clegg A; Scott DA; Sidhu M; Hewitson P; Waugh N
    Health Technol Assess; 2001; 5(32):1-195. PubMed ID: 12065068
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Chemoradiation for pancreatic adenocarcinoma].
    Flandin I; Mornex F; Claude L; Kubas A; Khodri M; Wautot V; Mazeron R; Partensky C
    Cancer Radiother; 2004 Nov; 8 Suppl 1():S80-7. PubMed ID: 15679252
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neoadjuvant chemoradiation to convert locally advanced pancreatic body adenocarcinoma to resectable disease.
    Cunningham SC; Cusnir M; Burdick RK; Van Echo DA; Moesinger R
    Clin Adv Hematol Oncol; 2003 Dec; 1(12):741-2; discussion 743. PubMed ID: 16258479
    [No Abstract]   [Full Text] [Related]  

  • 7. New perspectives in the management of pancreas cancer.
    Haller DG
    Semin Oncol; 2003 Aug; 30(4 Suppl 11):3-10. PubMed ID: 14506598
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A phase I-II study of gemcitabine and docetaxel in advanced pancreatic cancer: a report from the Italian Group for the Study of Digestive Tract Cancer (GISCAD).
    Cascinu S; Gasparini G; Catalano V; Silva RR; Pancera G; Morabito A; Giordani P; Gattuso D; Catalano G
    Ann Oncol; 1999 Nov; 10(11):1377-9. PubMed ID: 10631469
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comprehensive update on the use of chemotherapy for metastatic pancreatic adenocarcinoma.
    Kozuch P; Petryk M; Bruckner HW
    Hematol Oncol Clin North Am; 2002 Feb; 16(1):123-38. PubMed ID: 12063823
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Gemcitabine-based combinations in inoperable pancreatic cancers].
    Louvet C; André T; Artru P
    Bull Cancer; 2002 Aug; 89 Spec No():S96-101. PubMed ID: 12449038
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Past and present treatment of pancreatic adenocarcinoma: chemotherapy as a standard treatment modality.
    Abbruzzese JL
    Semin Oncol; 2002 Dec; 29(6 Suppl 20):2-8. PubMed ID: 12577227
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gemcitabine-based combination treatment of pancreatic cancer.
    Heinemann V
    Semin Oncol; 2002 Feb; 29(1 Suppl 3):25-35. PubMed ID: 11894005
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical update of gemcitabine in pancreas cancer.
    Au E
    Gan To Kagaku Ryoho; 2000 May; 27 Suppl 2():469-73. PubMed ID: 10895197
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Docetaxel/Gemcitabine followed by gemcitabine and external beam radiotherapy in patients with pancreatic adenocarcinoma.
    Pipas JM; Barth RJ; Zaki B; Tsapakos MJ; Suriawinata AA; Bettmann MA; Cates JM; Ripple GH; Sutton JE; Gordon SR; McDonnell CE; Perez RP; Redfield N; Meyer LP; Marshall JF; Cole BF; Colacchio TA
    Ann Surg Oncol; 2005 Dec; 12(12):995-1004. PubMed ID: 16252135
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of gemcitabine in the treatment of advanced and metastatic breast cancer.
    Heinemann V
    Oncology; 2003; 64(3):191-206. PubMed ID: 12697958
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Present and future treatment of pancreatic cancer.
    Heinemann V
    Semin Oncol; 2002 Jun; 29(3 Suppl 9):23-31. PubMed ID: 12094335
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combination gemcitabine and docetaxel therapy in advanced adenocarcinoma of the pancreas.
    Sherman WH; Fine RL
    Oncology; 2001; 60(4):316-21. PubMed ID: 11408799
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recent advances in managing non-small-cell lung cancer: 4. Chemotherapy of metastatic cancer.
    Clarke SJ; Boyer MJ
    Med J Aust; 1997 Jun; 166(S1):S14-6. PubMed ID: 9201199
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Nab-paclitaxel use in pancreatic cancer: practical aspects and consequences in a French oncology day-care unit].
    Hubault M; Faure R; Walter T; Forestier J; Lombard-Bohas C; Pivot C
    Bull Cancer; 2015 May; 102(5):403-4. PubMed ID: 25866372
    [No Abstract]   [Full Text] [Related]  

  • 20. Preoperative chemoradiation for patients with pancreatic cancer: toxicity of endobiliary stents.
    Pisters PW; Hudec WA; Lee JE; Raijman I; Lahoti S; Janjan NA; Rich TA; Crane CH; Lenzi R; Wolff RA; Abbruzzese JL; Evans DB
    J Clin Oncol; 2000 Feb; 18(4):860-7. PubMed ID: 10673529
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.